Kyobo Life to sell maiden won-denominated hybrid bond next month Hybrid bond sale likely to help improve insurer's financial structure
Translated by Kim So-in 공개 2021-08-23 08:13:42
이 기사는 2021년 08월 20일 08시01분 thebell에 표출된 기사입니다
Kyobo Life Insurance plans to raise as much as 500 billion won ($425 million) from its maiden won-denominated hybrid bond sale to improve its financial structure.Kyobo Life and its bookrunners, KB Securities and Korea Investment & Securities, are preparing to issue a hybrid bond to secure liquidity, industry sources said on Wednesday. The issuer is expected to start a book building process and issue the bond in mid-September.
The issuer has tentatively decided to raise 300 billion won through the issuance. The amount could be increased to 500 billion won if the bond is oversubscribed during the book building process in early September.
This will be the life insurer’s first offering of a hybrid bond, which is regarded as an asset, instead of debt, in financial statements.
Kyobo Life has issued mezzanine debts whenever it needed to secure liquidity and improve the financial structure. In July 2017, the life insurer raised about $500 million in its offering of a foreign currency-denominated hybrid bond. It was the first time a domestic life insurer sold a hybrid bond in the Korean paper market. Korean paper refers to foreign currency debt issued by South Korean entities abroad. The bond was underwritten by Citigroup Global Markets Korea Securities, JP Morgan, Nomura Securities, and UBS.
Kyobo Life plans to use the proceeds from the issuance to repay borrowings and increase its capital base, as its total capital decreased from 12.9 trillion won on a consolidated basis at the end of last year to 11.9 trillion won at the end of June this year. (Reporting by Chul Kang)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- '비상경영체 돌입' SKT, 유심 사태 수습 '총력전'
- 위메이드 "위믹스 해킹 늑장공시 아니야…DAXA 기준 불분명"
- [Market Watch]DN솔루션즈 이어 롯데글로벌까지, 대형 IPO '휘청'
- [롯데글로벌로지스 IPO]흥행 실패 우려, 결국 상장 철회로 귀결
- [AACR 2025]제이인츠 'JIN-001', 독성 최소화한 '저농도' 효능 입증
- [Financial Index/SK그룹]주가상승률 50% 상회, SK스퀘어 'TSR' 그룹내 최고
- 금호타이어, 분기 '최대 매출'…영업이익은 '주춤'
- 유지한 SKC CFO "트럼프 관세, 위기보다 기회"
- [i-point]신테카바이오, 'K-BioX 글로벌 SUMMIT 6' 참여
- 간추려진 대명소노그룹 선택지, '티웨이'에 집중